Replimune Group, Inc.
REPL · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $4,575 |
| Gross Profit | $0 | $0 | $0 | -$4,575 |
| % Margin | – | – | – | – |
| R&D Expenses | $189,447 | $174,963 | $126,527 | $80,645 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $36,264 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $72,180 | $59,810 | $50,553 | $0 |
| Operating Expenses | $261,627 | $234,773 | $177,080 | $116,909 |
| Operating Income | -$261,627 | -$234,773 | -$177,080 | -$121,484 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $14,798 | $19,387 | $3,084 | $278 |
| Pre-Tax Income | -$246,829 | -$215,386 | -$173,996 | -$121,206 |
| Tax Expense | $468 | $408 | $288 | -$3,170 |
| Net Income | -$247,297 | -$215,794 | -$174,284 | -$118,036 |
| % Margin | – | – | – | – |
| EPS | -3.07 | -3.24 | -2.99 | -2.26 |
| % Growth | 5.2% | -8.4% | -32.3% | – |
| EPS Diluted | -3.07 | -3.24 | -2.99 | -2.26 |
| Weighted Avg Shares Out | 80,564 | 66,570 | 58,213 | 52,212 |
| Weighted Avg Shares Out Dil | 80,564 | 66,570 | 58,213 | 52,212 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21,120 | $23,356 | $10,006 | $390 |
| Interest Expense | $7,893 | $6,660 | $4,160 | $2,223 |
| Depreciation & Amortization | $5,929 | $5,083 | $2,447 | $4,575 |
| EBITDA | -$253,924 | -$227,770 | -$171,719 | -$114,408 |
| % Margin | – | – | – | – |